PL3133083T3 - Wielostopniowa filtracja końcowa - Google Patents

Wielostopniowa filtracja końcowa

Info

Publication number
PL3133083T3
PL3133083T3 PL16188558T PL16188558T PL3133083T3 PL 3133083 T3 PL3133083 T3 PL 3133083T3 PL 16188558 T PL16188558 T PL 16188558T PL 16188558 T PL16188558 T PL 16188558T PL 3133083 T3 PL3133083 T3 PL 3133083T3
Authority
PL
Poland
Prior art keywords
final filtration
multistep
multistep final
filtration
final
Prior art date
Application number
PL16188558T
Other languages
English (en)
Inventor
Roberto Falkenstein
Klaus Schwendner
Original Assignee
F. Hoffmann-La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F. Hoffmann-La Roche Ag filed Critical F. Hoffmann-La Roche Ag
Publication of PL3133083T3 publication Critical patent/PL3133083T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065Purification, fragmentation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/34Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/36Extraction; Separation; Purification by a combination of two or more processes of different types
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/32Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Oncology (AREA)
  • Analytical Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Water Supply & Treatment (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Fats And Perfumes (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
PL16188558T 2009-10-01 2010-09-29 Wielostopniowa filtracja końcowa PL3133083T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP09012460 2009-10-01
EP16188558.7A EP3133083B1 (en) 2009-10-01 2010-09-29 Multistep final filtration
EP10757795.9A EP2483305B1 (en) 2009-10-01 2010-09-29 Multistep final filtration of immunoglobulin
PCT/EP2010/064487 WO2011039274A1 (en) 2009-10-01 2010-09-29 Multistep final filtration

Publications (1)

Publication Number Publication Date
PL3133083T3 true PL3133083T3 (pl) 2020-09-07

Family

ID=41466840

Family Applications (2)

Application Number Title Priority Date Filing Date
PL16188558T PL3133083T3 (pl) 2009-10-01 2010-09-29 Wielostopniowa filtracja końcowa
PL10757795T PL2483305T3 (pl) 2009-10-01 2010-09-29 Wieloetapowa końcowa filtracja immunoglobuliny

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL10757795T PL2483305T3 (pl) 2009-10-01 2010-09-29 Wieloetapowa końcowa filtracja immunoglobuliny

Country Status (21)

Country Link
US (4) US20120231506A1 (pl)
EP (3) EP3715369A1 (pl)
JP (1) JP5458183B2 (pl)
KR (3) KR101653471B1 (pl)
CN (3) CN103980346A (pl)
AU (1) AU2010302662B2 (pl)
BR (1) BR112012004054B1 (pl)
CA (1) CA2773674C (pl)
CY (1) CY1118577T1 (pl)
DK (1) DK2483305T3 (pl)
ES (2) ES2604103T3 (pl)
HK (2) HK1200178A1 (pl)
HR (2) HRP20161693T1 (pl)
HU (1) HUE030186T2 (pl)
IL (2) IL217626A (pl)
LT (1) LT2483305T (pl)
MX (1) MX342442B (pl)
PL (2) PL3133083T3 (pl)
PT (1) PT2483305T (pl)
SI (2) SI3133083T1 (pl)
WO (1) WO2011039274A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111902720B (zh) 2018-03-21 2025-02-07 沃特世科技公司 基于非抗体高亲和力的样品制备、吸附剂、装置和方法
CN111007242A (zh) * 2019-12-20 2020-04-14 苏州和迈精密仪器有限公司 基于多层高分子多孔膜的荧光免疫检测方法、装置及应用

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643566A (en) 1982-09-23 1997-07-01 Cetus Corporation Formulation processes for lipophilic proteins
US4488961A (en) 1982-09-29 1984-12-18 E. I. Du Pont De Nemours And Company One-way filter unit
US4592848A (en) * 1984-12-11 1986-06-03 Pabst Richard E Flow through filter with backflush clearing capability
CS247484B1 (cs) * 1985-04-12 1987-01-15 Eva Hamsikova Způsob přípravy imunoglobulinu proti lidským Iymfocytům
WO1989006692A1 (en) 1988-01-12 1989-07-27 Genentech, Inc. Method of treating tumor cells by inhibiting growth factor receptor function
DE3818860A1 (de) 1988-06-03 1989-12-07 Seitz Filter Werke Filterelement
WO1992022653A1 (en) 1991-06-14 1992-12-23 Genentech, Inc. Method for making humanized antibodies
DE4204444C1 (pl) 1992-02-14 1993-05-19 Krankenhausentsorgungs Gmbh, 1000 Berlin, De
WO1997004801A1 (en) 1995-07-27 1997-02-13 Genentech, Inc. Stabile isotonic lyophilized protein formulation
DK1897890T3 (da) 1996-11-27 2010-04-06 Genentech Inc Affinitetsoprensning af polypeptid på en protein A matrix
CN103641885A (zh) 1998-05-06 2014-03-19 基因技术股份有限公司 用离子交换层析纯化蛋白质
US6984494B2 (en) * 2000-08-15 2006-01-10 Genentech, Inc. Analytical method
WO2003066662A2 (en) 2002-02-05 2003-08-14 Genentech, Inc. Protein purification
JP2005530845A (ja) * 2002-06-21 2005-10-13 アイデック ファーマシューティカルズ コーポレイション 抗体を濃縮するための緩衝化処方物およびその使用方法
JPWO2004031385A1 (ja) * 2002-10-04 2006-02-02 麒麟麦酒株式会社 ヒト人工染色体(hac)ベクター
WO2004087761A1 (ja) 2003-03-31 2004-10-14 Kirin Beer Kabushiki Kaisha ヒトモノクローナル抗体およびヒトポリクローナル抗体の精製
GB0316560D0 (en) * 2003-07-15 2003-08-20 Chiron Srl Vesicle filtration
AU2005247950B2 (en) * 2004-05-27 2012-02-02 Receptor Logic, Inc. Antibodies as T cell receptor mimics, methods of production and uses thereof
WO2006023831A2 (en) * 2004-08-20 2006-03-02 Prometic Biosciences Ltd. Sequential protein isolation and purification schemes by affinity chromatography
US20060051347A1 (en) * 2004-09-09 2006-03-09 Winter Charles M Process for concentration of antibodies and therapeutic products thereof
CA2586130A1 (en) * 2004-11-22 2006-05-26 Oxygenix Co., Ltd. Reagent containing oxygen isotope-labeled hemoglobin for examining vital tissue and method of producing the same
TWI306862B (en) 2005-01-03 2009-03-01 Hoffmann La Roche Antibodies against il-13 receptor alpha 1 and uses thereof
PL2620450T3 (pl) * 2005-03-08 2019-05-31 Pfizer Prod Inc Kompozycje przeciwciała anty-CTLA-4
JPWO2007018316A1 (ja) 2005-08-09 2009-02-19 武田薬品工業株式会社 癌の予防・治療剤
CN101534920B (zh) * 2006-11-01 2013-10-16 比奥根艾迪克Ma公司 通过低ph和二价阳离子分离生物大分子的方法
AR067536A1 (es) 2007-07-17 2009-10-14 Hoffmann La Roche Metodo para obtener una eritropoyetina mono-pegilada en una forma sustancialmente homogenea
KR101215740B1 (ko) * 2007-07-17 2012-12-27 루드비히-막시밀리안스-우니버지테트 뮌헨 가변적 접선류 여과
WO2009058769A1 (en) 2007-10-30 2009-05-07 Schering Corporation Purification of antibodies containing hydrophobic variants
EP2346900A1 (en) 2008-10-29 2011-07-27 Wyeth LLC Methods for purification of single domain antigen binding molecules
ES2706190T3 (es) * 2012-10-30 2019-03-27 Hoffmann La Roche Purificación de polipéptidos utilizando ultrafiltración de flujo tangencial de dos fases

Also Published As

Publication number Publication date
HRP20200588T1 (hr) 2020-07-10
EP2483305B1 (en) 2016-09-21
CN102574913A (zh) 2012-07-11
IL217626A (en) 2017-12-31
US20120231506A1 (en) 2012-09-13
AU2010302662A1 (en) 2012-02-09
EP3133083A1 (en) 2017-02-22
PL2483305T3 (pl) 2017-03-31
US11891430B2 (en) 2024-02-06
CA2773674C (en) 2017-08-29
KR20140091763A (ko) 2014-07-22
KR101718301B1 (ko) 2017-03-20
BR112012004054A2 (pt) 2020-08-11
HUE030186T2 (en) 2017-04-28
CA2773674A1 (en) 2011-04-07
IL255658A (en) 2018-01-31
US20180009878A1 (en) 2018-01-11
HK1210183A1 (en) 2016-04-15
ES2787403T3 (es) 2020-10-16
JP5458183B2 (ja) 2014-04-02
KR20160104739A (ko) 2016-09-05
US20240228589A9 (en) 2024-07-11
BR112012004054B1 (pt) 2021-09-08
CN104610447A (zh) 2015-05-13
CN103980346A (zh) 2014-08-13
KR101653471B1 (ko) 2016-09-01
US20240132574A1 (en) 2024-04-25
EP3133083B1 (en) 2020-02-19
EP3715369A1 (en) 2020-09-30
SI2483305T1 (sl) 2017-01-31
US20200291097A1 (en) 2020-09-17
DK2483305T3 (en) 2016-10-24
WO2011039274A1 (en) 2011-04-07
LT2483305T (lt) 2016-11-25
AU2010302662B2 (en) 2015-11-26
HRP20161693T1 (hr) 2017-02-24
JP2013505733A (ja) 2013-02-21
CY1118577T1 (el) 2017-07-12
ES2604103T3 (es) 2017-03-03
KR101508044B1 (ko) 2015-04-07
HK1200178A1 (en) 2015-07-31
KR20120053522A (ko) 2012-05-25
EP2483305A1 (en) 2012-08-08
MX342442B (es) 2016-09-29
PT2483305T (pt) 2016-11-04
MX2012003727A (es) 2012-04-30
SI3133083T1 (sl) 2020-07-31

Similar Documents

Publication Publication Date Title
DK2442650T4 (en) Sublingualt apomorfin
GB201103481D0 (en) No details
GB201016096D0 (en) No details
GB201016097D0 (en) No details
GB0900138D0 (en) Filtering speech
GB0904558D0 (en) Membranes
PL2387446T3 (pl) Kombinacyjny filtr
GB0922659D0 (en) Factor H
IL216039A0 (en) Concatamers for immunemodulation
GB2468770B (en) Drainage arrangement
GB0916769D0 (en) Water filter
IL255658A (en) Multi-stage final filtering
GB201006421D0 (en) Filter
GB0910950D0 (en) Filtration
HU0900073V0 (en) Water filter
GB0914067D0 (en) Filter means
GB2470588B (en) Drawing aid
GB0900587D0 (en) Can final removal
GB0921794D0 (en) Can final removal
AU4926P (en) Bonscalib Scaevola aemula
AU4925P (en) Bonscawi Scaevola aemula
AU4924P (en) Bonscablue Scaevola aemula
GB0917632D0 (en) Filter
GB0917567D0 (en) Filter
GB0914267D0 (en) Waterpoint filter